Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03212274
What this trial is testing

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmGlioblastomaRecurrent Cholangiocarcinoma+4 more
National Cancer Institute (NCI) 89
Early research (Phase 1)Ended earlyNCT02620839
What this trial is testing

Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies

Who this might be right for
Solid Tumors
Pamela Munster 28
Testing effectiveness (Phase 2)Study completedNCT03994601
What this trial is testing

An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 219
Very early researchNot Yet RecruitingNCT07266311
What this trial is testing

CAR-T for Claudin18.2 Positive Solid Tumors

Who this might be right for
Claudin18.2 Positive Advanced Solid Tumors
Chengdu Ucello Biotechnology Co., Ltd. 18
Early research (Phase 1)Not Yet RecruitingNCT07391644
What this trial is testing

JSKN027 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 250
Early research (Phase 1)Ended earlyNCT04975256
What this trial is testing

Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplasm of Colon+2 more
Mirati Therapeutics Inc. 7
Early research (Phase 1)Study completedNCT03745807
What this trial is testing

An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 3
Early research (Phase 1)Ended earlyNCT06573294
What this trial is testing

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid TumorsMetastatic Malignant Solid Tumors
Genmab 23
Early research (Phase 1)Looking for participantsNCT07292402
What this trial is testing

JSKN022 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 225
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873
What this trial is testing

Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor MalignanciesMalignant Mesothelioma (MM)
TYK Medicines, Inc 219
Early research (Phase 1)WithdrawnNCT04372641
What this trial is testing

Testing the Safety of CB-5339 in Patients With Cancer

Who this might be right for
Aggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaLocally Advanced Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT06432296
What this trial is testing

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Who this might be right for
Malignant Ascites
Wuhan YZY Biopharma Co., Ltd. 312
Early research (Phase 1)UnknownNCT05416359
What this trial is testing

Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT05170958
What this trial is testing

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
Nanjing Leads Biolabs Co.,Ltd 396
Early research (Phase 1)Ended earlyNCT02187848
What this trial is testing

Evaluation of SAR408701 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Malignant
Sanofi 254
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Early research (Phase 1)Study completedNCT00225121
What this trial is testing

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 121
Early research (Phase 1)Looking for participantsNCT05691517
What this trial is testing

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 35
Next Page